17 results on '"Paulukonis S"'
Search Results
2. 278 Emergency Department Utilization by Californians With Sickle Cell Disease, 2005-2014
- Author
-
Paulukonis, S., primary, Vichinsky, E., additional, Neumayr, L., additional, Treadwell, M., additional, Coates, T., additional, Feuchtbaum, L., additional, and Hulihan, M., additional
- Published
- 2016
- Full Text
- View/download PDF
3. Emergency department 30-Day emergency department revisits among people with sickle cell disease: Variations in characteristics.
- Author
-
Rushing M, Horiuchi S, Zhou M, Kavanagh PL, Reeves SL, Snyder A, and Paulukonis S
- Subjects
- Humans, Male, Female, Adolescent, Child, Adult, Child, Preschool, Young Adult, Georgia epidemiology, Infant, California epidemiology, United States epidemiology, Patient Readmission statistics & numerical data, Medicaid statistics & numerical data, Middle Aged, Infant, Newborn, Anemia, Sickle Cell therapy, Anemia, Sickle Cell epidemiology, Emergency Service, Hospital statistics & numerical data
- Abstract
People with sickle cell disease (SCD) often have emergency department (ED) revisits. The characteristics of people with SCD with ED revisits were assessed in this study using Medicaid administrative claims data from California and Georgia, representing 2794 and 3641 individuals with SCD, respectively. In both states, those with 6+ primary care provider (PCP) encounters had the highest percentage of ED revisits. In California, those with 6+ hematology encounters had the lowest percentage of individuals with an ED revisit; in Georgia, those with 1-2 hematology encounters. Increasing access to hematologic care may reduce ED revisits among people with SCD., (© The Author(s). Pediatric Blood & Cancer published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
4. National Quality Indicators in Pediatric Sickle Cell Anemia.
- Author
-
Anderson AT, Mack WJ, Horiuchi SS, Paulukonis S, Zhou M, Snyder AB, Doctor JN, Kipke M, Coates T, and Freed G
- Subjects
- Child, Humans, Quality Indicators, Health Care, Georgia epidemiology, Ultrasonography, Doppler, Transcranial, Stroke complications, Anemia, Sickle Cell epidemiology, Anemia, Sickle Cell complications
- Abstract
Objective: To assess nationally endorsed claims-based quality measures in pediatric sickle cell anemia (SCA)., Methods: Using data from the Sickle Cell Data Collection programs in California and Georgia from 2010 to 2019, we evaluated 2 quality measures in individuals with hemoglobin S/S or S/β-zero thalassemia: (1) the proportion of patients aged 3 months to 5 years who were dispensed antibiotic prophylaxis for at least 300 days within each measurement year and (2) the proportion of patients aged 2 to 15 years who received at least 1 transcranial Doppler ultrasound (TCD) within each measurement year. We then evaluated differences by year and tested whether performance on quality measures differed according to demographic and clinical factors., Results: Only 22.2% of those in California and 15.5% in Georgia met or exceeded the quality measure for antibiotic prophylaxis, with increased odds associated with rural residence in Georgia (odds ratio 1.61; 95% confidence interval 1.21-2.14) compared with urban residence and a trend toward increased odds associated with a pediatric hematologist prescriber (odds ratio 1.28; 95% confidence interval 0.97, 1.69) compared with a general pediatrician. Approximately one-half of the sample received an annual assessment of stroke risk using TCD (47.4% in California and 52.7% in Georgia), with increased odds each additional year in both states and among younger children., Conclusions: The rates of receipt of recommended antibiotic prophylaxis and annual TCD were low in this sample of children with SCA. These evidence-based quality measures can be tracked over time to help identify policies and practices that maximize survival in SCA., (Copyright © 2024 by the American Academy of Pediatrics.)
- Published
- 2024
- Full Text
- View/download PDF
5. Case Ascertainment of Sickle Cell Disease Using Surveillance or Single Administrative Database Case Definitions.
- Author
-
Reeves SL, Horiuchi S, Zhou M, Paulukonis S, Snyder A, Wilson-Frederick S, and Hulihan M
- Subjects
- Infant, Newborn, United States epidemiology, Humans, Georgia epidemiology, Data Collection, Patient Discharge, Databases, Factual, Anemia, Sickle Cell diagnosis, Anemia, Sickle Cell epidemiology
- Abstract
Objective: In the absence of access to surveillance system data, single-source administrative databases are often used to study health care utilization and health outcomes among people with sickle cell disease (SCD). We compared the case definitions from single-source administrative databases with a surveillance case definition to identify people with SCD., Materials and Methods: We used data from Sickle Cell Data Collection programs in California and Georgia (2016-2018). The surveillance case definition for SCD developed for the Sickle Cell Data Collection programs uses multiple databases, including newborn screening, discharge databases, state Medicaid programs, vital records, and clinic data. Case definitions for SCD in single-source administrative databases varied by database (Medicaid and discharge) and years of data (1, 2, and 3 years). We calculated the proportion of people meeting the surveillance case definition for SCD that was captured by each single administrative database case definition for SCD, by birth cohort, sex, and Medicaid enrollment., Results: In California, 7117 people met the surveillance case definition of SCD from 2016 through 2018; 48% of this group was captured by the Medicaid case definition and 41% by the discharge case definition. In Georgia, 10 448 people met the surveillance case definition of SCD from 2016 through 2018; 45% of this group was captured by the Medicaid case definition and 51% by the discharge case definition. These proportions differed by years of data, birth cohort, and length of Medicaid enrollment., Practice Implications: The surveillance case definition identified twice as many people with SCD as the single-source administrative database definitions during the same period, but trade-offs exist in using single administrative databases for decisions on policy and program expansion for SCD., Competing Interests: Declaration of Conflicting InterestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
6. Common data model for sickle cell disease surveillance: considerations and implications.
- Author
-
Smeltzer MP, Reeves SL, Cooper WO, Attell BK, Strouse JJ, Takemoto CM, Kanter J, Latta K, Plaxco AP, Davis RL, Hatch D, Reyes C, Dombkowski K, Snyder A, Paulukonis S, Singh A, and Kayle M
- Abstract
Objective: Population-level data on sickle cell disease (SCD) are sparse in the United States. The Centers for Disease Control and Prevention (CDC) is addressing the need for SCD surveillance through state-level Sickle Cell Data Collection Programs (SCDC). The SCDC developed a pilot common informatics infrastructure to standardize processes across states., Materials and Methods: We describe the process for establishing and maintaining the proposed common informatics infrastructure for a rare disease, starting with a common data model and identify key data elements for public health SCD reporting., Results: The proposed model is constructed to allow pooling of table shells across states for comparison. Core Surveillance Data reports are compiled based on aggregate data provided by states to CDC annually., Discussion and Conclusion: We successfully implemented a pilot SCDC common informatics infrastructure to strengthen our distributed data network and provide a blueprint for similar initiatives in other rare diseases., Competing Interests: Dr Matthew Smeltzer has worked as a paid research consultant for the Association of Community Cancer Centers. The findings and conclusions in this publication are those of the authors and do not necessarily represent the views of the North Carolina Department of Health and Human Services, Division of Public Health. No other authors have competing interests to declare., (© The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association.)
- Published
- 2023
- Full Text
- View/download PDF
7. Sickle cell disease among Latinx in California.
- Author
-
Valle J, Baker JR, Madrigal D, Ferrerosa J, and Paulukonis S
- Subjects
- Adult, Infant, Newborn, Female, United States epidemiology, Humans, Medicaid, Emergency Service, Hospital, California epidemiology, Delivery of Health Care, Anemia, Sickle Cell epidemiology, Anemia, Sickle Cell genetics, Anemia, Sickle Cell diagnosis
- Abstract
Introduction: After African Americans, Latinx are the second largest population affected by Sickle Cell Disease (SCD) in the U.S. However, research has largely ignored how this devastating rare blood disorder specifically affects Latinx nationwide., Methods: This study compared demographics, genotypes, primary insurance, and health care utilization among Latinx and non-Latinx Californians living with SCD, using data from the California SCD Data Collection Program (2016-2018) and newborn screening cases 2000-2017., Results: Stemming from 6,837 SCD patients, 501(7%) were Latinx. Latinx with SCD (Lx-SCD) were statistically significantly younger than non-Latinx (NLx-SCD) counterparts. Within both groups, females predominated, with 70% being insured by Medicaid. Mean Emergency Department encounters were statistically significantly lower among Lx-SCD adults., Discussion: Lx-SCD differ in age, genotype, and Emergency Department utilization, when compared to NLx-SCD counterparts in California. Latinx are now the largest racial and/or ethnic group in the US, and their presence in SCD population is expected to grow. Therefore, their specific demographic, genotypic, and health care utilization characteristics merit attention to inform policies and programs that will improve their health., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2022
- Full Text
- View/download PDF
8. Notes from the Field: Harmful Algal Bloom Affecting Private Drinking Water Intakes - Clear Lake, California, June-November 2021.
- Author
-
Solomon GM, Stanton B, Ryan S, Little A, Carpenter C, and Paulukonis S
- Subjects
- California epidemiology, Environmental Monitoring, Humans, Lakes, Drinking Water, Harmful Algal Bloom
- Abstract
Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- Published
- 2022
- Full Text
- View/download PDF
9. Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease.
- Author
-
Wong TE, Valle J, and Paulukonis S
- Abstract
Background and Aims: When patients with sickle cell disease have appropriate indications, they can be prescribed hydroxyurea (HU) and deferasirox (DFX) concurrently despite little knowledge about how the two medications interact. We wished to analyze whether there was evidence of adverse interaction between HU and DFX when taken simultaneously and hypothesized that those who took both drugs together had similar clinical complications when compared to those who took only one or neither drug., Methods: We conducted this retrospective cohort investigation between 2009 and 2016 of persons with SCD in the California Sickle Cell Data Collection Program, a validated database of Californians with SCD a statewide. People in the database who took HU and DFX simultaneously for at least 3 months as compared to those who took either HU or DFX alone or to matched persons who took neither drug were eligible., Results: We identified 104 people who were prescribed both HU and DFX concurrently, 877 who were prescribed HU only, and 314 who were prescribed DFX only during the study period. We identified 416 matched controls who took neither HU nor DFX. People who took both HU and DFX concurrently had similar rates of ED and inpatient encounters and had similar rates and distribution of adverse effects compared to those who took either HU or DFX alone or took neither drug., Conclusion: Three months of concurrent use of DFX and HU appears safe, but further studies are required to better understand the safety and effectiveness of this medication combination. (Funded by CDC, CDC Foundation, and others)., Competing Interests: The authors declare no competing financial interests., (© 2021 The Authors. Health Science Reports published by Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
10. Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease.
- Author
-
Kayle M, Valle J, Paulukonis S, Holl JL, Tanabe P, French DD, Garg R, Liem RI, Badawy SM, and Treadwell MJ
- Subjects
- Adolescent, Adult, Age Factors, California, Child, Emergency Service, Hospital, Female, Humans, Male, Middle Aged, United States, Anemia, Sickle Cell epidemiology, Anemia, Sickle Cell therapy, Databases, Factual, Drug Prescriptions, Health Services Accessibility, Hospitalization, Hydroxyurea administration & dosage, Medicaid
- Abstract
Purpose: Sickle cell disease (SCD) is associated with high acute healthcare utilization. The purpose of this study was to examine whether Medicaid expansion in California increased Medicaid enrollment, increased hydroxyurea prescriptions filled, and decreased acute healthcare utilization in SCD., Methods: Individuals with SCD (≤65 years and enrolled in Medicaid for ≥6 total calendar months any year between 2011 and 2016) were identified in a multisource database maintained by the California Sickle Cell Data Collection Program. We describe trends and changes in Medicaid enrollment, hydroxyurea prescriptions filled, and emergency department (ED) visits and hospital admissions before (2011-2013) and after (2014-2016) Medicaid expansion in California., Results: The cohort included 3635 individuals. Enrollment was highest in 2014 and lowest in 2016 with a 2.8% annual decease postexpansion. Although <20% of the cohort had a hydroxyurea prescription filled, the percentage increased by 5.2% annually after 2014. The ED visit rate was highest in 2014 and decreased slightly in 2016, decreasing by 1.1% annually postexpansion. Hospital admission rates were similar during the pre- and postexpansion periods. Young adults and adults had higher ED and hospital admission rates than children and adolescents., Conclusions: Medicaid expansion does not appear to have improved enrollment or acute healthcare utilization among individuals with SCD in California. Future studies should explore whether individuals with SCD transitioned to other insurance plans or became uninsured postexpansion, the underlying reasons for low hydroxyurea utilization, and the lack of effect on hospital admissions despite a modest effect on ED visits., (© 2020 Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
11. Acute Care Utilization at End of Life in Sickle Cell Disease: Highlighting the Need for a Palliative Approach.
- Author
-
Johnston EE, Adesina OO, Alvarez E, Amato H, Paulukonis S, Nichols A, Chamberlain LJ, and Bhatia S
- Subjects
- Aged, 80 and over, Death, Emergency Service, Hospital, Hospitalization, Humans, Middle Aged, Anemia, Sickle Cell therapy, Palliative Care
- Abstract
Background: People with sickle cell disease (SCD) have a life expectancy of <50 years, so understanding their end-of-life care is critical. Objective: We aimed to determine where individuals with SCD were dying and their patterns of care in the year preceding death to highlight end-of-life research priorities and possible opportunities for intervention. Design: Using the California SCD Data Collection Program database (containing administrative data, vital records, and Medicaid claims), we examined people with SCD who died between 2006 and 2015 (cases) at age <80 years and examined their hospital and emergency department (ED) utilization in their last year of life. Comparators included living controls with SCD matched 1:1 based on age, analysis year, insurance, and income. Results: We identified 486 people with SCD (cases) who died at a median age of 45 years (SD: 16 years). Most died in the hospital (63%) and ED (15%). In their last year of life, people with SCD were hospitalized for an average of 42 days (SD: 49 days) over five admissions. Inpatient admissions and ED visits were stable throughout the year until the month before death when acute care utilization sharply increased. In their last year of life, cases had more hospitalizations than controls, but similar ED utilization. Conclusions: People with SCD are dying acutely at a young age and most die in the hospital and the ED. Since clinicians caring for people with SCD currently cannot predict which acute events may be life-threatening, a comprehensive palliative approach to people with SCD must extend beyond chronic pain management and psychosocial support to include advance care planning.
- Published
- 2020
- Full Text
- View/download PDF
12. Providers' Perspectives on Treating Patients With Thalassemia.
- Author
-
Radke T, Paulukonis S, Hulihan MM, and Feuchtbaum L
- Subjects
- California, Humans, Surveys and Questionnaires, Practice Patterns, Physicians', Thalassemia
- Abstract
In recent years, California has experienced a steady rise in Asian immigration which has led to a corresponding increased prevalence of clinically significant thalassemia in this state. As part of the Public Health Research, Education and Surveillance for Hemoglobinopathies emoglobinopathies project, a survey was developed to collect information from California providers who care for thalassemia patients in an effort to better understand their practice patterns, barriers to providing care, and educational needs. When asked about educational needs, providers most frequently expressed a desire for care and management guidelines (65.3%), health educational materials for patients (47.2%), and information on complications and clinical outcomes (32.1%). Only one quarter of providers (24.0%) reported that all of their thalassemia patients have a coordinated care plan. The increase in California thalassemia cases highlights the importance of provider knowledge to effectively serve the patients in their communities. Provider education and dissemination of treatment standards can not only improve knowledge about the disease but also increase awareness about the importance of coordinating care among a multidisciplinary team of specialists. Improvement in these areas will help achieve the overarching goal of better outcomes and quality of life for patients with thalassemia.
- Published
- 2019
- Full Text
- View/download PDF
13. Cancer specific survival in patients with sickle cell disease.
- Author
-
Brunson A, Keegan THM, Mahajan A, Paulukonis S, and Wun T
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, California epidemiology, Comorbidity, Disease Susceptibility, Ethnicity statistics & numerical data, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Neoplasms epidemiology, Proportional Hazards Models, Risk, Sex Distribution, Young Adult, Anemia, Sickle Cell epidemiology, Neoplasms mortality
- Abstract
Sickle cell disease (SCD) patients have a higher incidence of certain cancers, but no studies have determined the impact of cancer on survival among SCD patients. SCD patients (n = 6423), identified from state-wide hospitalisation data, were linked to the California Cancer Registry (1988-2014). Multivariable Cox proportional hazards regression was used to examine survival. Among SCD patients, a cancer diagnosis was associated with a 3-fold increased hazard of death. Compared to matched cancer patients without SCD, SCD was associated with worse overall survival, but not cancer-specific survival, suggesting that SCD cancer patients should be treated with similar therapeutic intent., (© 2018 British Society for Haematology and John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
14. Increased risk of leukemia among sickle cell disease patients in California.
- Author
-
Brunson A, Keegan THM, Bang H, Mahajan A, Paulukonis S, and Wun T
- Subjects
- Adult, Anemia, Sickle Cell physiopathology, Breast Neoplasms epidemiology, California epidemiology, Cell Transformation, Neoplastic, Comorbidity, Female, Genital Neoplasms, Male epidemiology, Humans, Incidence, Inflammation, Male, Middle Aged, Neoplasms epidemiology, Retrospective Studies, Risk, Anemia, Sickle Cell epidemiology, Leukemia epidemiology
- Published
- 2017
- Full Text
- View/download PDF
15. Evaluating the Use of Electronic Health Records for Type 2 Diabetes Surveillance in 2 California Counties, 2010-2014.
- Author
-
Richardson MJ, Van Den Eeden SK, Roberts E, Ferrara A, Paulukonis S, and English P
- Subjects
- Adolescent, Adult, Black People statistics & numerical data, California, Chronic Disease epidemiology, Diabetes Mellitus, Type 2 ethnology, Female, Geography, Medical, Glycated Hemoglobin analysis, Health Status Disparities, Hispanic or Latino statistics & numerical data, Humans, Male, Middle Aged, Prevalence, Racial Groups, Social Class, White People statistics & numerical data, Black or African American, Diabetes Mellitus, Type 2 epidemiology, Electronic Health Records statistics & numerical data, Population Surveillance methods
- Abstract
Objectives: Electronic health records (EHRs) and electronic laboratory records (ELRs) are increasingly seen as a rich source of data for performing public health surveillance activities and monitoring community health status. Their potential for surveillance of chronic illness, however, may be underused. Our objectives were to (1) evaluate the use of EHRs and ELRs for diabetes surveillance in 2 California counties and (2) examine disparities in diabetes prevalence by geography, income, and race/ethnicity., Methods: We obtained data on a clinical diagnosis of diabetes and hemoglobin A1c (HbA1c) test results for adult members of Kaiser Permanente Northern California living in Contra Costa County or Solano County at any time during 2010-2014. We evaluated the validity of using HbA1c test results to determine diabetes prevalence, using clinical diagnoses as a gold standard. We estimated disparities in diabetes prevalence by combining HbA1c test results with US Census data on income, race, and ethnicity., Results: When compared with a clinical diagnosis of diabetes, data on a patient's 5-year maximum HbA1c value ≥6.5% yielded the best combination of sensitivity (87.4%) and specificity (99.2%). The prevalence of 5-year maximum HbA1c ≥6.5% decreased with increasing median family income and increased with greater proportions of residents who were either non-Hispanic black or Hispanic., Conclusions: Timely diabetes surveillance data from ELRs can be used to document disparities, target interventions, and evaluate changes in population health. ELR data may be easier to access than a patient's entire EHR, but outcome metric validation with diabetes diagnoses would need to be ongoing. Future research should validate ELR and EHR data across multiple providers.
- Published
- 2017
- Full Text
- View/download PDF
16. Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California.
- Author
-
Valle J, Roberts E, Paulukonis S, Collins N, English P, and Kaye W
- Subjects
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Female, Humans, Incidence, Los Angeles epidemiology, Male, Middle Aged, Retrospective Studies, San Francisco epidemiology, Urban Health Services, Young Adult, Amyotrophic Lateral Sclerosis epidemiology, Population Surveillance
- Abstract
Our objective was to provide demographic profiles and incidence estimates of amyotrophic lateral sclerosis (ALS) in two diverse California metropolitan areas: Los Angeles County (LA) and the San Francisco Bay Area (SFBA). Data were retrospectively collected from multiple sources. Case eligibility criteria included residency in SFBA or LA, and treatment for or diagnosis of ALS between 1 January 2009 and 31 December 2011. Overall incidence rates as well as age-, gender-, race- and ethnicity-specific rates were calculated. We identified 539 ALS cases in SFBA and 545 in LA; 618 were incident cases. Cases were more likely to be male and white. There were considerably more cases (p < 0.05) in LA who were foreign-born (LA, 22%; SFBA, 15%), black (LA, 10%; SFBA, 6%) or Hispanic (LA, 19%; SFBA, 10%). Conversely, the age adjusted incidence rates (per 100,000) were higher in SFBA for whites (LA, 1.40; SFBA, 2.49) and Hispanics (LA, 0.66; SFBA, 1.57) compared with LA. General case demographics and incidence rates in these two areas were similar to published studies. However, the differences between the two areas raise questions about how factors such as geography, access to care, and referral patterns may affect case ascertainment and diagnosis.
- Published
- 2015
- Full Text
- View/download PDF
17. Chart Card: feasibility of a tool for improving emergency department care in sickle cell disease.
- Author
-
Neumayr L, Pringle S, Giles S, Quirolo KC, Paulukonis S, Vichinsky EP, and Treadwell MJ
- Subjects
- Adolescent, Adult, Chi-Square Distribution, Child, Feasibility Studies, Female, Humans, Male, Software, User-Computer Interface, Anemia, Sickle Cell therapy, Emergency Service, Hospital organization & administration, Medical Records Systems, Computerized, Patient Satisfaction
- Abstract
Background: Patients with sickle cell disease (SCD) are concerned with emergency department care, including time to treatment and staff attitudes and knowledge. Providers are concerned about rapid access to patient information and SCD treatment protocols. A software application that stores and retrieves encrypted personal medical information on a plastic credit card-sized Chart Card was designed., Objective: To determine the applicability and feasibility of the Chart Card on patient satisfaction with emergency department care and provider accessibility to patient information and care protocols., Methods: One-half of 44 adults (aged -18 years) and 50 children with SCD were randomized to either the Chart Card or usual care. Patient satisfaction was surveyed pre and post implementation of the Chart Card program, and emergency department staff was surveyed about familiarity with SCD treatment protocols., Conclusion: Patient satisfaction with emergency department care and efficacy in health care increased post Chart Card implementation. Providers valued immediate access to patient information and SCD treatment guidelines. The technology has potential for application in the treatment of other illnesses in other settings.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.